PHARM · Study guide
Pharmacology study guide
Pharmacology is a pattern-recognition subject. Generic-name suffixes point to a drug class, the class predicts the mechanism, and the mechanism predicts the therapeutic effect, the adverse effects, and the nursing assessments. Learn the map once and you can reason your way through a drug you have never seen before.
On NCLEX-style exams, pharmacology is rarely pure recall. Items ask what to assess before giving a dose, which lab value or vital sign to check, what teaching a patient needs, and which adverse effect requires you to hold the drug and call the provider. This guide organizes the highest-yield patterns; use the quiz to drill them under exam conditions.
High-yield concepts
Suffixes map to classes
Name endings are the fastest route to a class. “-olol” is a beta blocker, “-pril” an ACE inhibitor, “-sartan” an ARB, “-statin” an HMG-CoA reductase inhibitor, “-prazole” a proton pump inhibitor, and “-floxacin” a fluoroquinolone antibiotic. Once you place the class, the assessment and teaching follow logically.
Beta blockers and the heart rate check
Beta blockers slow the heart and lower blood pressure, so the core nursing action is to check the apical pulse for a full minute before giving the dose and hold it if the rate is below 60 beats per minute. They blunt the tachycardia that normally warns of hypoglycemia, which matters for patients with diabetes, and they should not be stopped abruptly because of rebound hypertension and angina.
ACE inhibitors, ARBs, and potassium
ACE inhibitors and ARBs lower blood pressure and are protective in heart failure and diabetic kidney disease, but both can raise serum potassium, so monitor potassium and kidney function. A dry, persistent cough is the classic ACE-inhibitor effect (from bradykinin) and is a common reason to switch to an ARB. Angioedema is rare but is an emergency.
Anticoagulants and their monitoring
Warfarin works on vitamin-K–dependent clotting factors; it is monitored with the INR (a common therapeutic target is 2 to 3), reversed with vitamin K, and heavily affected by dietary vitamin K and drug interactions. Unfractionated heparin is monitored with the aPTT and reversed with protamine sulfate. Low-molecular-weight heparins such as enoxaparin generally do not need routine coagulation monitoring.
High-alert medications demand double checks
Certain drugs carry a heightened risk of serious harm when misused: insulin, heparin and other anticoagulants, concentrated electrolytes such as potassium chloride, opioids, and neuromuscular blockers. Institutional policy typically requires an independent double-check before administration. Never give potassium chloride by IV push — it must be diluted and infused slowly.
Know the common antidotes
Antidote pairings recur across exams: naloxone reverses opioids, flumazenil reverses benzodiazepines, acetylcysteine treats acetaminophen overdose, vitamin K reverses warfarin, protamine reverses heparin, and digoxin immune Fab treats severe digoxin toxicity. Recognizing the toxidrome tells you which reversal agent to reach for.
Therapeutic drug monitoring
Drugs with a narrow therapeutic index are dosed to a blood level, not just a milligram amount. Digoxin, lithium, vancomycin, phenytoin, and theophylline all have target ranges, and small changes push patients into toxicity. Recognize early toxicity — for digoxin, nausea, visual halos, and bradycardia; for lithium, tremor, confusion, and GI upset — and check the level before the next dose.
Timing and the peak/trough concept
For level-monitored drugs, timing of the blood draw matters. A trough is drawn just before the next dose and reflects the lowest concentration; a peak is drawn after distribution and reflects the highest. Reporting a level without the draw time relative to the dose makes it uninterpretable, which is why documentation of dose timing is a safety issue.
Common NCLEX-style traps
- “Hold the dose and notify the provider” is often correct when a vital sign or lab is out of range — but read whether the stem gives you a genuine parameter (pulse < 60, potassium > 5.0) or is just asking you to assess first.
- A drug’s expected side effect is not the same as an adverse effect that requires action. Nausea starting warfarin is expected; new bleeding is a reason to act.
- Watch for two drugs that both raise potassium (an ACE inhibitor plus a potassium-sparing diuretic) or both prolong QT — the item may be testing an interaction, not either drug alone.
- For level-monitored drugs, the safe answer usually involves checking the level or the last dose time before giving more — not simply administering because the order exists.
- “Take the full course” and “do not stop abruptly” apply to different drugs for different reasons (antibiotics vs. beta blockers/corticosteroids) — match the rationale to the drug.
Put it into practice
Ready to test what you just reviewed?
Study mode shows the rationale after every question, so a missed item still teaches the concept. A free account saves your scores and tracks your weak areas by topic.
Sources
- Burchum JR, Rosenthal LD. Lehne’s Pharmacology for Nursing Care. 12th ed. Elsevier; 2024.
- Institute for Safe Medication Practices (ISMP). List of High-Alert Medications in Acute Care Settings. 2024.
- Vallerand AH, Sanoski CA. Davis’s Drug Guide for Nurses. 18th ed. F.A. Davis; 2023.
This study guide is original content written for practice and study only — it is not medical advice and is not a substitute for clinical judgment, institutional policy, or the guidance of a licensed provider. Reference ranges and drug information vary by source and change over time; always confirm against current, authoritative references and your facility's policies. NCLEX® is a registered trademark of NCSBN, which does not endorse or sponsor this site.